INTRODUCTION {#SEC1}
============

To date, more than 100 modified nucleosides have been identified in tRNA ([@B1],[@B2]). Among them, queosine (Q) and archaeosine (G^+^) are unique because their structures contain the 7-deazaguanine: Q is \[7-(4, 5-cis-dihydroxy-2-cyclopenten-1-yl) amino\] methyl-7-deazaguanosine ([@B3]), while G^+^ is 7-formamidino-7-deazaguanosine (2-amino-4, 7-dihydro-4-oxo-7-β-D-ribofuranosyl-*1H*-pyrro \[2, 3-d\] pyrimidine-5- carboximidamide) (Figure [1](#F1){ref-type="fig"} and ref. [@B4]).

![Archaeosine biosynthesis pathway. The guanine base at position 15 in tRNA is replaced with preQ~0~ by ArcTGT. The resultant preQ~0~15 is further modified to G^+^15 by ArcS.](gkv1522fig1){#F1}

Q and G^+^ are introduced into tRNA by the base replacement reaction, which is catalyzed by tRNA-guanine transglycosylases (TGT) ([@B5],[@B6]). Q and its derivatives have been identified at position 34 in a subset of tRNAs (tRNA^Asp^, tRNA^Asn^, tRNA^His^ and tRNA^Tyr^), which have the GUN anticodons, from eubacteria and eukaryotes ([@B1]). The introduced Q and its derivatives reinforce the anticodon-codon interaction and prevent the frameshift error ([@B7]--[@B9]). In contrast, G^+^ has been identified at position 15 in tRNAs from archaea ([@B1]). A bioinformatics study predicted that G^+^15 stabilizes the L-shaped tRNA structure through reinforcement of the G15-C48 tertiary base pair ([@B10]).

In eubacterial tRNAs, eubacterial TGT (QueTGT) replaces the G34 base with 7-aminomethyl-7-deazaguanine (preQ~1~) ([@B11]), and the resultant preQ~1~34 is further modified to Q34 *via* epoxyqueosine34 by QueA ([@B12]) and QueG ([@B13]). In eukaryotes, Q base from a salvage system is directly used for the formation of Q34 by eukaryotic TGT ([@B14]). In archaea, archaeosine TGT (ArcTGT) exchanges the G15 base by 7-cyano-7-deazaguanine (preQ~0~) ([@B6],[@B15]) and the resultant preQ~0~15 is further modified to G^+^15 by archaeosine synthase (ArcS) ([@B16]--[@B18]) (Figure [1](#F1){ref-type="fig"}).

G^+^ was first identified at position 15 in tRNA^Met^m from *Thermoplasma acidophilum*, a thermo-acidophilic archaeon ([@B19],[@B20]) as an unknown modified nucleoside ([@B21]) and then found in tRNAs from archaea such as *Haloferax volcanii* ([@B22]), *Thermoproteus neutrophilus* ([@B23]), *Sulfolobus acidocaldarius* ([@B4]) and *Haloarcula marismortui* ([@B24],[@B25]). ArcTGT proteins and their genes have been experimentally identified in several archaea such as *H. volcanii* ([@B6],[@B26]), *Methanococcus janaschii* ([@B15]), *Pyrococcus horikoshii* ([@B27]--[@B29]), *Pyrococcus furiosus* ([@B30]), *Methanosarcina barkeri* ([@B30]) and *Methanosarcina acetivorans* ([@B31]), consistent with the wide spread of G^+^ in archaeal tRNAs.

In a recent study, we found that tRNA^Met^i from *T. acidophilum* contains G^+^ modification similar to that of tRNA^Met^m ([@B32]). Furthermore, we found that tRNA^Leu^~UAG~ from *T. acidophilum* has two G^+^ modifications at positions 13 and 15 ([@B33]) (see Figure [4A](#F4){ref-type="fig"}). Until now, the G^+^13 modification system has not been reported. Given that tRNA modification enzymes generally act on only one position in tRNA, the different positions are modified by different enzymes. For example, *N*^2^-methylguanine at position 6 (m^2^G6) in archaeal tRNA is conferred by Trm14 ([@B34]), while m^2^G10 ([@B35]) and m^2^G26 ([@B32],[@B36],[@B37]) in archaeal tRNA are formed by Trm-G10 and Trm1, respectively. In contrast, a few tRNA modification enzymes act on multiple sites in tRNA. For example, archaeal TrmI catalyzes *N*^1^-methyladenosine modifications at positions 57 and 58 ([@B38]). Furthermore, Trm1 from *Aquifex aeolicus*, a thermophilic eubacterium, brings about *N*^2^, *N*^2^-dimethylguanosine modifications at positions 26 and 27 ([@B39]). Thus, these limited numbers of enzymes have multisite-specificity. In this study, we focused on the biosynthesis of G^+^13 and G^+^15 in tRNA^Leu^. Because ArcTGT from *T. acidophilum* could not be expressed as a soluble protein in *Escherichia coli*, we employed the genetic manipulation system using another archaeon, *Thermococcus kodakarensis*. Furthermore, the structural role of G^+^13 and G^+^15 modifications in tRNA is discussed.

MATERIALS AND METHODS {#SEC2}
=====================

Materials {#SEC2-1}
---------

Guanine hydrochloride \[8--^14^C\] (2.19 MBq/mmol) was purchased from Moravek Biochemicals (Brea, CA, USA). Hitrap Q-Sepharose and Hitrap Heparin-Sepharose were bought from GE Healthcare (Tokyo, Japan). DNA oligomers were obtained from Invitrogen Japan (Tokyo, Japan). Other chemical reagents were of analytical grade.

Strain, media and culture {#SEC2-2}
-------------------------

The culture source of *T. acidophilum* strain HO-62 was a gift from Dr Akihiko Yamagishi (Tokyo University of Pharmacy and Life Science) ([@B20]). The strain was cultured at 56°C as described previously ([@B32]).

Solid-phase DNA probe method for tRNA purification {#SEC2-3}
--------------------------------------------------

Total RNA was prepared as described previously ([@B40]). The tRNA fraction was further purified by 10% PAGE (7 M urea). Transfer RNA^Cys^ and tRNA^Leu^ were purified from tRNA mixtures by the solid-phase DNA probe method ([@B40],[@B41]). The sequences of the DNA probes were complimentary to G15-A36 in tRNA^Cys^: 5′- TGC AGT CCC A[T]{.ul}G CAT GAC CTC -3′ and A16-G36 in tRNA^Leu^: 5′- CTA AAT CCA T[T]{.ul}G CCT TTG GCC AGT - biotin 3′. Because m^2^~2~G modifications were expected at position 26 in both tRNA, T was used instead of C as the complimentary nucleotide (the T are underlined).

MALDI-MS spectrometry {#SEC2-4}
---------------------

Desalting of the tRNA^Leu^ samples was performed with a ZipTip~C18~ (Merck Millipore Ltd.). Briefly, RNA solution containing 0.1 A260 units of tRNA^Cys^ or tRNA^Leu^ was aspirated and dispensed through a ZipTip~C18~. The ZipTip~C18~ was washed with 20 mM triethylamine acetate (pH 6.9), and the tRNA was eluted with 20 μl acetonitrile. The sample was then dried with a centrifugal evaporator and dissolved in 5 μl water. An aliquot (1.5 μl) of the sample was mixed with 1.5 μl RNase T1 solution \[50 mM triethylammonium bicarbonate (pH 7.0) and 4 units/μl RNase T1\] or RNase A solution \[50 mM triethylammonium bicarbonate (pH 7.0) and 100 μg/ml RNase A (Roche)\] and incubated at 37°C for 2 h. The reaction mixture was then incubated at 65°C for 5 min and then further incubated at 37°C for 2 h. After the digestion, 1 μl of the RNA digest was mixed with 1 μl MALDI matrix \[20 mg/ml 3-hydroxypicolinic acid and 5 mg/ml diammonium hydrogen citrate in 45% (v/v) acetonitrile, and 0.045% (v/v) trifluoroacetic acid\] and the mixture was spotted onto a MALDI plate. The RNA fragments on the plate were analyzed in the positive ion mode using an AXIMA Resonance^TM^ MALDI-QIT-TOF mass spectrometer system (Shimadzu).

Preparation of *T. acidophilum* tRNA^Leu^ transcript {#SEC2-5}
----------------------------------------------------

The transcripts were prepared using T7 RNA polymerase, and purified by Q-Sepharose column chromatography and 10% polyacrylamide gel containing 7 M urea electrophoresis \[PAGE (7 M urea)\].

Purification of *P. horikoshii* ArcTGT {#SEC2-6}
--------------------------------------

ArcTGT from *P. horikoshii* was expressed in *E. coli* BL21 (DE3) Rosetta 2 strain (Novagen) and purified as described previously ([@B27]).

Cloning, expression and purification of *T. kodakarensis* ArcTGT {#SEC2-7}
----------------------------------------------------------------

The *T. kodakarensis arcTGT* (TK0760) gene was amplified by polymerase chain reaction (PCR) from *T. kodakarensis* genomic DNA using the following primers : TK0760F primer, 5′- GGA GAT ATA [CAT ATG]{.ul} GTC GAT TTC AGG TTT GAG GT -3′; TK0760R primer, 5′- GAA TTC [GGA TCC]{.ul} TCA TAA CTA CTT CTC GAC TCC CCT CCT A -3′. Underlined regions show restriction enzyme sites (NdeI and BamHI). The PCR product was cloned into the expression vector pET30a (Novagen). The expression of recombination protein in *E.coli* BL21 (DE3) Rosetta 2 strain was performed according to the manufacture\'s manual. ArcTGT from *T. kodakarensis* was purified by heat treatment at 70°C for 30 min, followed by successive rounds of column chromatography through HiTrap Q-Sepharose and HiTrap Heparin-Sepharose. The final eluted sample was dialyzed against buffer A \[50 mM Tris-HCl (pH7.6), 600 mM KCl, 10 μM ZnCl~2~ and 1 mM DTT\]. Glycerol was added to the sample to a final concentration of 50% v/v and the sample was stored at --30°C.

Preparation of *T. acidophilum* S-30 fraction {#SEC2-8}
---------------------------------------------

*Thermoplasma acidophilum* cell extract was prepared as previously described ([@B42]). In brief, frozen cells (0.5 g) were suspended in 5 ml H~2~O supplemented with 50 μl of an EDTA-free protease inhibitor cocktail (Thermo Scientific), and then collected by centrifugation at 4000 × *g* at 4ºC for 10 min. The cells were resuspended in 1 ml DNase I buffer \[40 mM Tris-HCl (pH7.9), 10 mM NaCl, 6 mM MgCl~2~ and 1 mM CaCl~2~\] supplemented with 10 μl of an EDTA-free protease inhibitor cocktail, and the pH was then adjusted to 7.5 with 2 M Trizma base. After the pH adjustment, 100 units DNase I (Roche) was added, and the sample was incubated on ice for 1 h. The sample was centrifuged at 30 000 × *g* at 4ºC for 10 min. The supernatant fraction was used as the supernatant fraction of centrifugation at 30 000 × *g* (S-30).

Measurement of ^14^C-guanine base exchanging activity {#SEC2-9}
-----------------------------------------------------

Guanine exchanging activity was measured as follows: 30 μg of proteins from the S-30 fraction (or 1 μg purified ArcTGT from *P. horikoshii* or *T. kodakarensis*), 0.1 A260 units tRNA^Leu^ transcript and 1.69 nmol ^14^C-guanine in 20 μl buffer B \[50 mM Tris-HCl (pH7.6), 50 mM KCl, 5 mM MgCl~2~ and 6 mM 2-mercaptoethanol\] were incubated at 55°C for 30 min. The RNA was extracted with phenol-chloroform and then recovered by ethanol precipitation. The RNA pellet was dissolved in 5 μl H~2~O, and then separated by 10% PAGE (7 M urea). The gel was stained with methylene blue, and dried. The incorporation of ^14^C-guanine base into the tRNA was monitored with a Typhoon FLA 7000 laser scanner (GE Healthcare).

Genetic manipulations using *T. kodakarensis* {#SEC2-10}
---------------------------------------------

The outline of genetic manipulations using *T. kodakarensis* in this study, the construction of *T. kodakarensis* strain KUWA, the *T. kodakarensis ΔarcTGT* strain, and Ta1493 gene complimentary (KTA1493) strain, and the expression of tRNA^Leu^ in the KTA1493 strain are described in the Supplementary data (Supplementary Figures S1--S8).

Nucleoside analysis {#SEC2-11}
-------------------

Nucleoside analysis was performed after complete digestion of tRNA with phosphodiesterase, RNase A and bacterial alkaline phosphatase as described previously ([@B43]). The elution point of G^+^ was confirmed by MS analysis.

Preparation of the anti-Ta1493 gene product polyclonal antibody fraction and western blotting analysis {#SEC2-12}
------------------------------------------------------------------------------------------------------

The Ta1493 coding region was amplified by PCR from *T. acidophilum* genomic DNA using the following primers: Ta1493F 5′- GGA GAT ATA [CAT ATG]{.ul} AAG ATA GAG GAA AGG GAC GG -3′; Ta1493R 5′- GAA TTC [GGA TCC]{.ul} TCA CTA TTT CTC TGA TTG ATC TCT GCC -3′. Underlines indicate the restriction enzyme sites (NdeI and BamHI). The PCR product was inserted into the linker of pET30a expression vector. The *Escherichia coli* BL21 (DE3) Rosetta 2 strain was used for the expression. The cells (1 g) were suspended in 10 ml buffer B, and sonicated in an ultrasonic disruptor (model VCX-500, Sonics and Materials Inc, USA) at 4ºC. The cell debris was collected by centrifugation at 6000 x *g* at 4ºC for 15 min. This precipitate was dissolved in 5 ml buffer B containing 6 M guanidine-HCl. The sample was centrifuged at 16 000 x *g* at 4ºC for 15 min and the supernatant fraction was diluted by addition of 45 ml buffer B. The diluted sample was centrifuged at 16 000 x *g* at 4ºC for 15 min, and then the precipitant was dissolved in 6 ml buffer B containing 2 M urea. The sample was centrifuged at 16 000 x g at 4ºC for 15 min and the supernatant fraction was used as the antigen. Customized rabbit anti-Ta1493 gene product serum was prepared by Kitayama Labes (Nagano, Japan). Polyclonal antibody fractions were prepared using an Econo-pac serum IgG purification kit (Bio-Rad). Western blotting analysis was performed as described previously ([@B44]). The cell extracts of *T. kodakarensis* were prepared as follows. The *ΔarcTGT* and KTA1493 strains were cultured at 60 or 85ºC. When cell densities were reached at 0.7 A~660~, the cells in 250 μl medium were collected, added 10 μl of 2 × SDS-PAGE loading buffer \[100 mM Tris--HCl (pH 6.8), 200 mM dithiothreitol, 2.5% SDS, 0.2% bromophenol blue and 20% glycerol\], boiled for 5 min and then used for 15% SDS-PAGE.

RESULTS {#SEC3}
=======

The Ta1493 gene product was the only candidate for ArcTGT from *T. acidophilum*. {#SEC3-1}
--------------------------------------------------------------------------------

Genome sequencing demonstrated that *T. acidophilum* genome contains only around 1500 open reading frames ([@B45]). Our previous BLAST-search suggested that only one set of genes for ArcTGT (Ta1493) and ArcS (Ta0924) is encoded in the *T. acidophilum* genome ([@B33]). Comparison of the amino acid sequence of Ta1493 gene product with that of ArcTGT from *P. horikoshii* showed a high sequence similarity between the two proteins except for the insertions in the Ta1493 gene product (Figure [2A](#F2){ref-type="fig"}). However, the Ta1493 gene product has three insertions in the C1 and C2 domains, and the CXCX~2~CX~22~H (CCCH) motif, which binds a Zn atom (Figure [2B](#F2){ref-type="fig"} and ref. [@B28]), is missing. In addition, the amino acid sequence around the guanine binding site, Gln169, in *P. horikoshii* ArcTGT is different from that in the Ta1493 gene product (Figure [2A](#F2){ref-type="fig"}). In the crystal structure of *P. horikoshii* ArcTGT-tRNA complex, tRNA was captured by three parts, the catalytic domain, the C-terminal region of C2 domain and the C3 (PUA) domain ([@B29]). Thus, three insertions in the Ta1493 gene product were predicted not to be located in the tRNA binding sites. Furthermore, split-type ArcTGTs from *H. volcanii* ([@B26]), *M. barkeri* ([@B30]) and *M. acetivorans* ([@B31]) lack a connection region between the C1 and C2 domains. Nevertheless, these split-type ArcTGTs have enzymatic activity ([@B26],[@B30],[@B31]). Moreover, the deletion of C3 (PUA) domain in *P. furiosus* ArcTGT decreased the affinity for tRNA but did not cause the loss of enzymatic activity ([@B30]). Therefore, we considered that the three insertions in the C1 and C2 domains in the Ta1493 gene product do not cause the loss of enzymatic activity. In addition, the Zn binding site is located opposite to the catalytic pocket in *P. horikoshii* ArcTGT (Figure [2B](#F2){ref-type="fig"}). Thus, the bound Zn is not involved in the catalytic reaction ([@B28]). Based on these observations, we considered that the presence of three insertions and absence of the Zn binding site in Ta1493 gene product did not cause the loss of enzymatic activity. Thus, the Ta1493 gene product was a candidate for ArcTGT from *T. acidophilum*.

![(**A**) Comparison of the domain structures of *P. horikoshii* ArcTGT and *T. acidophilum* Ta1493 gene product. ArcTGT from *P. horikoshii* is composed of four domains, catalytic, C1, C2 and C3 (PUA) domains. The guanine- and Zn-binding sites in the catalytic domain are highlighted: Q\* in the NATIQ sequence binds the G15 base. In contrast, the Ta1493 gene product possesses three insertions in the C1 and C2 domains and the Zn-binding site (CCCH motif) is missing. In addition, the amino acid sequence around the guanine binding site is different from that in *P. horikoshii* ArcTGT. (**B**) Structure of *P. horikoshii* ArcTGT. Three insertion sites are shown by red triangles.](gkv1522fig2){#F2}

*Thermoplasma acidophilum* tRNA^Cys^ possesses unmodified G13 and G^+^15 {#SEC3-2}
------------------------------------------------------------------------

The G13 sequence is often observed in tRNA^Leu^, tRNA^Ser^ and tRNA^Cys^ not only from archaea, but also from eubacteria and eukaryotes ([@B1]). However, the RNA sequences of only three tRNA species (tRNA^Cys^, tRNA^Leu^~UAA~ and tRNA^Ser^~GGA~ from *H. volcanii*) apart from *T. acidophilum* tRNA^Leu^ are available in archaeal tRNA and these tRNAs have unmodified G13 ([@B1]). In the *T. acidophilum* tRNAs, tRNA^Cys^ possesses G13 and G15 in addition to tRNA^Leu^ (Figure [3A](#F3){ref-type="fig"}). We considered that both G13 and G15 in tRNA^Cys^ may be modified to G^+^13 and G^+^15 like tRNA^Leu^ in living *T. acidophilum* cells. To confirm this idea, we purified tRNA^Cys^ from total RNA by the solid-phase DNA probe method (Figure [3B](#F3){ref-type="fig"}). In *T. acidophilum* tRNAs, the amount of tRNA^Cys^ is considerably low: only 0.12 A260 units tRNA^Cys^ was purified from 50.0 A260 units *T. acidophilum* total RNA. This tRNA^Cys^ was digested with RNase T1 and then analyzed by MS spectrometry. Figure [3C](#F3){ref-type="fig"} shows the 600--2400 *m*/*z* region. In this region, AG^+^AGp (*m*/*z* = 1408.2) could be detected: the sequence was determined by MS/MS analysis (Figure [3D](#F3){ref-type="fig"}). Thus, tRNA^Cys^ possessed unmodified G13 and G^+^15, showing that the G^+^13 and G^+^15 modifications is tRNA^Leu^-specific in *T. acidophilum* cells. Although we focused on the G13 and G15 modifications in this experiment, MS analysis detected Cm32, m^1^G37, Cm56 and m^1^A58 modifications in tRNA^Cys^ (data not shown).

![(**A**) Cloverleaf structure of *T. acidophilum* tRNA^Cys^. The DNA probe for purification was hybridized with the G15-A36 region in this tRNA. (**B**) *T. acidophilum* total RNA (left, 0.3 A260 units) and purified tRNA^Cys^ (right, 0.015 A260 units) were analyzed by 10% PAGE (7 M urea). The gel was stained with toluidine blue. (**C**) The purified tRNA^Cys^ (0.03 A260 units) was digested with RNase T1 and its fragments were analyzed by MS spectrometry. The sequence of fragment (m/z = 1408.2) was determined by MS/MS analysis (**D**) as AG^+^AGp.](gkv1522fig3){#F3}

G^+^13 formation is not explainable by the structural equilibrium of tRNA^Leu^ and the activity of already-known ArcTGTs {#SEC3-3}
------------------------------------------------------------------------------------------------------------------------

To confirm whether Ta1493 is involved in the G^+^13 formation, we attempted to express the Ta1493 gene product in *Escherichia coli*. However, the recombinant protein could not be expressed in a soluble form (data not shown). To overcome this problem, we devised an expression system of Ta1493 gene product in another archaeon, *Thermococcus kodakarensis*.

Before constructing the expression system, we checked whether the G^+^13 formation was not caused by the structural equilibrium (change) of tRNA^Leu^ and the activity of an already-known ArcTGT. Figure [4A](#F4){ref-type="fig"} shows the cloverleaf structure of tRNA^Leu^ from *T. acidophilum*. If there is a structural equilibrium, in which the location of G13 in the D-loop is changed as shown in Figure [4B](#F4){ref-type="fig"}, an already-known ArcTGT may catalyze the exchange reaction of G13. Furthermore, the crystal structural study of ArcTGT-tRNA complex revealed that the L-shaped tRNA structure was changed to the λ-form in the complex ([@B29]). Therefore, the D-loop structure in tRNA^Leu^ might be changed by an already-known ArcTGT during the complex formation. To exclude these possibilities, we performed *in vitro* guanine base exchanging experiments. Four types of tRNA^Leu^ transcripts were prepared (Figure [4C](#F4){ref-type="fig"}). The wild-type tRNA^Leu^ transcript possessed G13 and G15. The G13 and/or G15 were replaced by A in the other mutant tRNA^Leu^ transcripts. As shown in Figure [4D](#F4){ref-type="fig"}, we purified *P. horikoshii* ArcTGT as an already-known ArcTGT because its tRNA recognition mechanism ([@B27]) and structure ([@B28],[@B29]) have been well-characterized. Furthermore, *T. kodakarensis* ArcTGT was also expressed in *E. coli* and purified (Figure [4D](#F4){ref-type="fig"}) because the Ta1493 gene product was planned to be expressed in *T. kodakarensis* cells. We prepared the cell extract (S-30 fraction) from *T. acidophilum* instead of the Ta1493 gene product (Figure [4D](#F4){ref-type="fig"}). ^14^C-guanine incorporation into tRNA^Leu^ transcripts was tested using purified ArcTGTs or the *T. acidophilum* S-30 fraction. As shown in Figure [4D](#F4){ref-type="fig"}, *P. horikoshii* ArcTGT exchanged only the guanine base at position 15 with ^14^C-guanine. Similarly, *T. kodakarensis* ArcTGT exchanged only the guanine base at position 15. In contrast, *T. acidophilum* S-30 exchanged guanine bases at both positions 13 and 15. These results clearly showed that the G^+^13 formation was not explainable by the structural change of tRNA^Leu^ and the activity of an already-known ArcTGT. Thus, the guanine base exchanging activity for G13 exists in the *T. acidophilum* S-30 fraction. The time-course experiments revealed that the *T. acidophilum* S-30 fraction preferentially exchanged the G13 by ^14^C-guanine as compared to the G15 (Figure [4E](#F4){ref-type="fig"}).

![*In vitro* guanine exchanging activities of purified ArcTGT and S-30 fraction from *T. acidophilum*. (**A**) Cloverleaf structure of tRNA^Leu^~UAG~ from *T. acidophilum*. Two G^+^ (G^+^13 and G^+^15) modifications are present in this tRNA. Abbreviations of other modified nucleosides are as follows: 4-thiouridine, s^4^U; *N*^2^, *N*^2^-dimethylguanosine, m^2^~2~G; 5-carbamoylmethyuridine, ncm^5^U; *N*^1^-methylguanosine, m^1^G; 7-methylguanosine, m^7^G; pseudouridine, Ψ; 2′-*O*-methylcytidine, Cm; *N*^1^-methyladenosine, m^1^A. (**B**) Possibility of structural change in the D-arm of tRNA^Leu^. (**C**) The cloverleaf structures of wild-type and mutant tRNA^Leu^ transcripts. The G13 and/or G15 in the wild-type tRNA^Leu^ were substituted by A in mutant tRNA^Leu^ transcripts. The nucleosides at positions 13 and 15 are highlighted in black. (**D**) *In vitro* guanine exchanging activity of purified ArcTGT and *T. acidophilum* S-30 fraction. To verify whether the purified ArcTGTs and S-30 fraction from *T. acidophilum* exchange the guanine base at position 13, ArcTGTs from *P. horikoshii* (left) and *T. kodakarensis* (middle) were purified and the S-30 fraction was prepared from *T. acidophilum* cells (right). The proteins were analyzed by SDS-PAGE. The gels were stained with Coomassie Brilliant Blue. ^14^C-guanine exchanging activities were tested using these proteins and tRNA^Leu^ transcripts. After the reaction, tRNA transcripts were extracted with phenol-chloroform, recovered by ethanol precipitation and separated by 10% PAGE (7 M urea). The RNAs were visualized by staining with methylene blue. Autoradiograms of the gels were acquired. (**E**) Time-course experiments of ^14^C-guanine exchanging activity in *T. acidophilum* S-30 fraction were performed. The samples were taken at 0, 5, 10 and 20 min-periods and loaded onto 10% polyacrylamide gels, which contained 7 M urea. The RNAs were visualized by methylene blue staining and autoradiograms of the gels were acquired.](gkv1522fig4){#F4}

Construction of *T. kodakarensis arcTGT* gene disruption strain {#SEC3-4}
---------------------------------------------------------------

In this study, we developed a new *T. kodakarensis* strain, KUWA, to construct an *arcTGT* gene disruption (*ΔarcTGT*) strain (Supplementary Figure S1). This strain was derived from *T. kodakarensis* strain KUW1 ([@B46],[@B47]). Because the strain KUWA is auxotrophic for uracil, tryptophan, and agmatine, multiple gene selection is possible. At the beginning of this study, we assumed that unknown factor(s) for structural change of tRNA^Leu^ in the S-30 fraction and ArcS might be required for the G^+^13 modification in addition to ArcTGT. Therefore, we constructed the strain KUWA for multiple gene selection. In this study, we used the auxotrophy for uracil to construct the *ΔarcTGT* (Supplementary Figure S2) and Ta1493 gene complimentary (TKA1493) (Supplementary Figure S3) strains, and auxotrophy for agmatine to supply tRNA^Leu^ genes by plasmid vectors. Details are available in the Supplementary information.

The *arcTGT* (Tk0760) gene in the genome of *T. kodakarensis* strain KUWA was disrupted by the method described in the Supplementary information. We successfully isolated candidate clones and their DNA sequences in the recombinant regions were verified (data not shown). As shown in Figure [5A](#F5){ref-type="fig"}, nucleosides derived from tRNA mixture of *T. kodakarensis* strain KUWA contained G^+^. In contrast, the peak of G^+^ disappeared in the sample from the *ΔarcTGT* strain (Figure [5B](#F5){ref-type="fig"}). Taking these results together, we concluded that the *ΔarcTGT* strain was successfully constructed.

![Construction of the *T. kodakarensis* Δ*arcTGT* strain. (**A**) Nucleoside analysis of tRNA mixtures from the KUWA strain. The tRNA fraction (0.2 A260 units) from KUWA strain was analyzed by 10% PAGE (7 M urea) (left panel). The gels were stained with toluidine blue. The tRNA mixtures were digested to nucleosides and then analyzed by HPLC C~18~-reverse-phase column chromatography (right panel). (**B**) Modified nucleosides in the tRNA fraction from the *ΔarcTGT* strain were analyzed by the same method.](gkv1522fig5){#F5}

Complementation of *ΔarcTGT* strain with the Ta1493 gene {#SEC3-5}
--------------------------------------------------------

Next, we constructed the strain complementary to the *ΔarcTGT* strain expressing the Ta1493 gene (KTA1493 strain) (Supplementary Figure S2). The expression of Ta1493 gene in the KTA1493 strain was verified by western blotting analysis (Figure [6A](#F6){ref-type="fig"}). We prepared a rabbit anti-Ta1493 gene product polyclonal antibody. The precipitated Ta1493 gene product in *E. coli* cells was dissolved in 6 M guanidine-HCl and then used as the antigen. When the KTA1493 strain was cultured at 60ºC, the band corresponding to the Ta1493 gene product was clearly observed (Figure [6A](#F6){ref-type="fig"} right panel). In contrast, this band was not observed in the sample from the *ΔarcTGT* strain, demonstrating that this band was derived from the complimented Ta1493 gene. When the KTA1493 and *ΔarcTGT* strains were cultured at 85ºC, the band disappeared, suggesting that the Ta1493 gene product was denatured and degraded at 85ºC. This result is in line with the fact that *T. acidophilum* grows optimally at 56ºC ([@B20]).

![Construction of the KTA1493 strain. (**A**) Western blotting analysis. The expression of Ta1493 gene product was assessed by western blotting analysis. Proteins from the *ΔarcTGT* and KTA1493 strains cultured at 60 or 85°C were separated by 15% SDS-PAGE (left) and western blotting analysis was performed (right). (**B**) Nucleoside analysis in tRNA fractions from the KTA1493 strain, which was cultured at 60ºC (upper panels) and 85ºC (lower panels). 0.2 A260 units of tRNA fractions were analyzed by 10% PAGE (7 M urea) (left panels). The gels were stained with toluidine blue. Modified nucleosides in tRNA fractions were analyzed (right panels). (**C**) Nucleoside analysis in tRNA fraction from the KUWA strain, which was cultured at 60ºC. 0.2 A260 units of tRNA fractions were analyzed by 10% PAGE (7 M urea) (left panels). The gels were stained with toluidine blue. Modified nucleosides in the tRNA fraction were analyzed (right panel).](gkv1522fig6){#F6}

The nucleoside analysis of tRNA mixture from the KTA1493 strain cultured at 60ºC revealed the presence of G^+^ (Figure [6B](#F6){ref-type="fig"} upper panel). In contrast, the peak of G^+^ disappeared in the sample from the KTA1493 strain cultured at 85ºC (Figure [6B](#F6){ref-type="fig"} lower panel), consistent with the results of western blotting analysis. Thus, these results showed that the Ta1493 gene product was expressed in the *T. kodakarensis ΔarcTGT* strain at 60ºC. It is also clear that the Ta1493 gene product is ArcTGT from *T. acidophilum*. Furthermore, a fragment containing preQ~0~ was not detected (data not shown). Therefore, the base exchanging reaction by *T. acidophilum* ArcTGT seemed to be the rate-limiting step of G^+^13 and G15^+^ formations. It should be mentioned that the activity of *T. acidophilum* ArcTGT in the KTA1493 strain was considerably weak as compared to the activity of *T. kodakarensis* ArcTGT in the KUWA (wild-type) strain (Figure [6C](#F6){ref-type="fig"}). Therefore, in the KTA1493 strain, tRNAs are not fully modified by introduced *T. acidophilum* ArcTGT.

Analysis of the wild-type and mutant tRNA^Leu^ expressed in the *T. kodakarensis* Ta1493 complementary strain suggested that G13 was modified to G^+^13 by *T. acidophilum* ArcTGT {#SEC3-6}
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

To verify whether *T. acidophilum* ArcTGT (Ta1493 gene product) was specific toward G13 and G15, we expressed *T. acidophilum* wild-type and mutant tRNA^Leu^ (Figure [4C](#F4){ref-type="fig"}) using plasmids in the KTA1493 strain at 60ºC: tRNA^Leu^ was constitutively expressed under the glutamate dehydrogenase promoter (Figure [7A](#F7){ref-type="fig"}). The expression of these tRNA was assessed by northern hybridization (Figure [7B](#F7){ref-type="fig"}). The probe sequence was complimentary to G36-A16 in the wild-type tRNA^Leu^. Fortunately, this probe did not hybridize with tRNAs from *T. kodakarensis* strain KTA1493 (with empty vector), but hybridized with the expressed tRNA^Leu^ (Figure [7B](#F7){ref-type="fig"} right panel). Thus, *T. acidophilum* wild-type and mutant tRNA^Leu^ were successfully expressed in the KTA1493 strain. The expressed tRNA^Leu^ variants were purified by the solid-phase DNA probe method ([@B40],[@B41]) as shown in Figure [7C](#F7){ref-type="fig"}. The nucleoside analysis revealed that G^+^ was formed in the wild-type, the A13G15 mutant, and the G13A15 mutant tRNA^Leu^ (Figure [7D](#F7){ref-type="fig"}). In contrast, G^+^ was not formed in the A13A15 mutant tRNA^Leu^ (Figure [7D](#F7){ref-type="fig"}). These results strongly suggested that G^+^ was formed at both positions 13 and 15.

![G^+^ formation in the wild-type and mutant tRNA^Leu^ expressed in the KTA1493 strain. (**A**) Schematic representation of the wild-type and mutant tRNA^Leu^ expression system. Plasmid vectors, expressing the wild-type or mutant tRNA^Leu^ gene were constructed. The wild-type and mutant tRNA^Leu^ were constitutively expressed under the glutamate dehydrogenase promoter. The transformants were selected by culture in medium without agmatine, which is synthesized by the *pdaD* gene product (pyruvoyl-dependent arginine decarboxylase). The Rep74 region is the plasmid origin for maintenance in *T. kodakarensis* cells. (**B**) Northern blotting analysis. Transfer RNA mixtures (0.2 A260 units each) from the KTA1493 strain expressing plasmids were separated by 10% PAGE (7 M urea) (left). The tRNA mixture from the *T. kodakarensis* KTA1493 strain with empty vector was prepared as a negative control (right side). The gel was stained with methylene blue. Northern blotting analysis was performed with a ^32^P-labeled DNA probe, which was complimentary to G36-A16 in the wild-type tRNA^Leu^. (**C**) The wild-type and mutant tRNA^Leu^ were purified by the solid-phase DNA probe method. The probe sequence was the same as the probe used for northern blotting analysis. 0.04 A260 units of purified tRNAs were analyzed by 10% PAGE (7 M urea). The gel was stained with toluidine blue. (**D**) G^+^ formation in the purified tRNA^Leu^. The purified wild-type and mutant tRNA^Leu^ were digested to nucleosides, and G^+^ formation in the samples was analyzed.](gkv1522fig7){#F7}

Mass spectrometry analysis revealed that G^+^ was formed at both positions 13 and 15 in the wild-type tRNA^Leu^ {#SEC3-7}
---------------------------------------------------------------------------------------------------------------

The position(s) of G^+^ in the wild-type tRNA^Leu^ expressed in the KTA1493 strain was determined by MALDI-MS analysis. In this experiment, we prepared the wild-type tRNA^Leu^ expressed in the *T. kodakarensis* strain, KUWA, as a control. This control tRNA^Leu^ was purified, digested with RNase A, and its fragments were analyzed. Figure [8A](#F8){ref-type="fig"} shows the 1600--1800 *m/z* value region. In this region, a GAG^+^ACp fragment (*m/z* = 1713.2) corresponding to G13-C17 in tRNA^Leu^ could be detected: the sequence was determined by the MS/MS analysis of this fragment (Figure [8B](#F8){ref-type="fig"}). Furthermore, MS/MS analysis revealed other fragments (*m/z* = 1672.3 and 1703.3) in Figure [8A](#F8){ref-type="fig"} were derived from the unmodified G13-C17 fragment and anticodon-loop, respectively (data not shown). Thus, G^+^ was formed only at position 15 in the wild-type tRNA^Leu^ expressed in the *T. kodakarensis* strain, KUWA, consistent with the result of the *in vitro* guanine exchanging activity of *T. kodakarensis* ArcTGT (Figure [4D](#F4){ref-type="fig"}).

![MALDI-MS analysis of the wild-type tRNA^Leu^. (**A**) The wild-type tRNA^Leu^ was expressed in *T. kodakarensis* strain KUWA and purified as a control. The purified tRNA^Leu^ was digested with RNaseA and its fragments were then analyzed by MALDI-MS spectrometry. In this region, a fragment (*m/z* = 1713.2), which coincided with the expected *m/z* value of the G13-C17 fragment (GAG^+^ACp) in the wild-type tRNA^Leu^, was detected. (**B**) The fragment sequence (*m/z* = 1713.2) was determined by MS/MS analysis as GAG^+^ACp. (**C**) The RNaseA-digested fragments derived from the wild-type tRNA^Leu^ expressed in the KTA1493 strain were analyzed by the same method as (A). In the 1600--1800 *m/z* region, a new fragment (*m/z* = 1754.3) appeared. (**D**) The sequence of this fragment (*m/z* = 1754.3) was determined as G^+^AG^+^ACp, which corresponded to the G^+^13-C17 fragment in the wild-type tRNA^Leu^. (**E**) Two fragments (G^+^AGACp and GAG^+^ACp; *m*/*z* = 1713.2) were detected by MS/MS analysis.](gkv1522fig8){#F8}

In contrast, when the wild-type tRNA^Leu^ was expressed in the KTA1493 strain, a new fragment (*m/z* = 1754.3) appeared in this region (Figure [8C](#F8){ref-type="fig"}). MS/MS analysis revealed that this fragment was G^+^AG^+^ACp corresponding to G^+^13-C17 in tRNA^Leu^ (Figure [8D](#F8){ref-type="fig"}). Thus, G^+^ was formed at both positions 13 and 15 in the wild-type tRNA^Leu^. Taking these experimental results together, we concluded that *T. acidophilum* ArcTGT (Ta1493 gene product) has a multisite specificity and is responsible for the formation of both G^+^13 and G^+^15 in tRNA^Leu^. Furthermore, G^+^AGACp and GAG^+^ACp (*m/z* = 1713.2) appeared in addition to G^+^AG^+^ACp in the wild-type tRNA^Leu^ expressed in the KTA1493 strain (Figure [8E](#F8){ref-type="fig"}), demonstrating that there is no order in G13 and G15 modification by the expressed *T. acidophilum* ArcTGT in *T. kodakarensis* cells. This is in line with the time-course experiments by the *T. acidophilum* S-30 fraction: the S-30 fraction exchanged the G13 and G15 in *T. acidophilum* tRNA^Leu^ transcript by ^14^C-guanine independently although the speed of exchanging of G13 was faster than that of G15 (Figure [4E](#F4){ref-type="fig"}). Moreover, two tRNA^Leu^ species from *T. kodakarensis* possess G13 and G15 (Supplementary Figure S9A). The difference of these two tRNA^Leu^ species is only one position (the first letter of anticodon). Although the DNA probe for purification was designed to be complimentary to tRNA^Leu^UAG (Supplementary Figure S9A), the separation of these tRNA^Leu^ species was difficult. Therefore, we purified two tRNA^Leu^ species as the mixture (Supplementary Figure S9B). MS analysis revealed that the positions 13 and 15 in tRNA^Leu^ species were identified as unmodified G13 and G15 (Supplementary Figure S9C and D). This phenomenon is probably caused by the weak activity of *T. acidophilum* ArcTGT in the *T. kodakarensis* cells. Given that the formation of G^+^ was observed in the tRNA mixture (Figure [6B](#F6){ref-type="fig"}), the other tRNA species seemed to be modified preferentially. This result showed that *T. acidophilum* tRNA^Leu^ is a very good substrate for *T. acidophilum* ArcTGT. The sequence (architecture) of *T. acidophilum* tRNA^Leu^ is required for the multisite specificity of *T. acidophilum* ArcTGT.

DISCUSSION {#SEC4}
==========

In this study, we demonstrated that ArcTGT from *T. acidophilum* possesses specificity not only for G15, but also for G13 *T. acidophilum* tRNA^Leu^. This multisite specificity brings two G^+^ modifications, G^+^13 and G^+^15, in *T. acidophilum* tRNA^Leu^.

The ArcTGT from *T. acidophilum* possesses three insertions and does not have the Zn-binding site as compared to the *P. horikoshii* ArcTGT. Given that many variations exist in the C1 and C2 domains of ArcTGTs, the insertions in *T. acidophilum* ArcTGT do not seem to be directly related to its multisite-specificity. The Zn-binding site is missing in some ArcTGTs. For example, ArcTGT from *Ferroplasma acidarmanus* does not have the CCCH motif, the Zn-binding site ([@B48]). Although *T. acidophilum* and *F. acidarmanus* are acidophilic archaea, the absence of Zn-binding site is not explainable by the availability of Zn under the acidic environment: the solubility of ZnSO~4~ is very high (540 g/1 L water at 20ºC). Indeed, ArcTGT from *S. acidocaldarius*, an acidophilic archaeon, has the CCCH motif ([@B49]). Therefore, the absence of Zn-binding site is not specific for ArcTGTs from acidophilic archaea.

The C3 (PUA) domain deletion mutant of *P. furiosus* ArcTGT precisely recognizes the target guanine at position 15 ([@B30]). ArcTGT from *P. horikoshii* recognizes the ribose-phosphate backbone in the D-arm and aminoacyl-stem ([@B27]). These studies suggest that the interaction between the catalytic domain and ribose-phosphate backbone in tRNA determines the specificity of ArcTGTs. In the current study, we confirmed that *P. horikoshii* and *T. kodakarensis* ArcTGTs act only on the G15 base (Figure [3D](#F3){ref-type="fig"}). In the complex of *P. horikoshii* ArcTGT and tRNA, the ribose at position 13, the phosphate between positions 12 and 13, and the phosphate between positions 13 and 14 are captured by Glu202, Tyr204 and Arg261 residues, respectively ([@B29]). These amino acid residues are highly conserved in ArcTGTs, including *T. acidophilum* ArcTGT. However, amino acid sequences around the catalytic pockets in ArcTGTs are considerably different from each other (Figure [2](#F2){ref-type="fig"}). This difference around the catalytic pocket may be involved in the multisite-specificity of *T. acidophilum* ArcTGT. Several ArcTGTs (for example, *F. acidarmanus* ArcTGT) share homology with *T. acidophilum* ArcTGT in this region ([@B48]). Given that the G13 sequence is widely observed in tRNA^Leu^, tRNA^Ser^ and tRNA^Cys^ ([@B1]), the G^+^13 modification may exist in tRNAs from several archaea in addition to *T. acidophilum*. ArcTGT recognizes the ribose-phosphate backbone in the D-arm and aminoacyl-stem ([@B27]) and changes the tRNA structure during the formation of tRNA-ArcTGT complex ([@B29]). In this study, we found that the sequence of *T. acidophilum* tRNA^Leu^ is required for the G^+^13 formation. In the case of multisite specific Trm1 ([@B39]), the distance between the catalytic center and tRNA binding site is longer than that of single site specific Trm1 ([@B50],[@B51]). This sequence and rule mechanism may be applicable for the tRNA recognition mechanism of *T. acidophilum* ArcTGT. Further studies are required to clarify this point.

It should be mentioned that the substrate tRNA recognition mechanism of ArcTGT is completely different from that of QueTGT. QueTGT recognizes the U33G34U35 sequence in the anticodon-loop ([@B52]) and the T-arm structure prevents incorrect G53 recognition ([@B53]). This tRNA recognition mechanism by QueTGT confers the Q34 modification in specific tRNAs (tRNA^His^, tRNA^Asn^, tRNA^Tyr^ and tRNA^Asp^). In contrast, ArcTGT recognizes the ribose-phosphate backbone in the D-arm and aminoacyl-stem ([@B27]). This tRNA recognition mechanism by ArcTGT brings the broad substrate tRNA specificity: sixteen of the 33 sequenced tRNAs from *H. volcanii* possess G^+^15 modifications ([@B22]). QueTGT from *Shigella flexneri* acts on the mRNA of virulence gene (*virF*) in addition to tRNA ([@B54],[@B55]). Because ArcTGTs have broader substrate specificity than QueTGTs, ArcTGTs may act on RNA(s) other than tRNA.

Because *T. acidophilum* proteome analysis indicated that many proteins form large protein complexes ([@B56]), *T. acidophilum* ArcTGT may interact with other proteins in living cells. Indeed, we attempted the purification of 6 x His-tag *T. acidophilum* ArcTGT expressed in the *T. kodakarensis ΔarcTGT* strain. However, the purified 6 x His-tag *T. acidophilum* ArcTGT was precipitated during the dialysis (data not shown). To maintain the solubility of *T. acidophilum* ArcTGT, the interaction with other proteins may be required. The insertions in the C1 and C2 domains might be involved in this interaction. To clarify whether interaction(s) of ArcTGT with other proteins exist in *T. acidophilum* cells, further study is required. However, it is clear that *T. acidophilum* ArcTGT possesses a multisite specificity because the introduction of *T. acidophilum* Ta1493 gene into the *T. kodakarensis ΔarcTGT* strain caused the formation of both G^+^13 and G^+^15.

In the L-shaped structure of yeast tRNA^Phe^, G15 forms a tertiary base pair with C48 and the *N*^7^-atom in the G15 constitutes one of the Mg^2+^ binding sites ([@B57]--[@B59]). The replacement of guanine base at position 15 by deazaguanine in G^+^ may abolish the Mg^2+^ binding site. A bioinformatics study predicted that this replacement gives the positive charge of G^+^15 and results in the reinforcement of the G^+^15-C48 tertiary base pair ([@B10]). Because tRNA^Leu^ and tRNA^Ser^ have a long variable region ([@B1]), the interaction between the D-arm and variable region is different from that in yeast tRNA^Phe^ (Figure [9A](#F9){ref-type="fig"} and [B](#F9){ref-type="fig"}). The crystal structure of tRNA^Leu^, which contains G13 and G15, has not been reported. However, fortunately, the crystal structure of *T. thermophilus* tRNA^Ser^, which contains G13 and G15, has been reported (Figure [9A](#F9){ref-type="fig"} and ref. [@B60]): G13 interacts with A22 and G9 (Figure [9C](#F9){ref-type="fig"}) and G15 forms tertiary base pairs with C48 and D20a (Figure [9D](#F9){ref-type="fig"}). G9 and D20a in tRNA^Ser^ are replaced by s^4^U9 and A20, respectively, in *T. acidophilum* tRNA^Leu^. Therefore, the accurate interactions of G^+^13-G9 and G^+^15-A20 are unknown. However the location of 7-formamidino groups in G^+^13 and G^+^15 (indicated in red in Figure [9C](#F9){ref-type="fig"} and [D](#F9){ref-type="fig"}) can be predicted from the G13-A22 and G15-C48 tertiary base pairs in tRNA^Ser^. As shown in Figure [9C](#F9){ref-type="fig"} and [D](#F9){ref-type="fig"}, introduced 7-formamidino groups in G^+^13 and G^+^15 do not cause steric hindrance with tertiary base pairs and may interact with phosphate groups. Therefore, G^+^13 and G^+^15 modifications in *T. acidophilum* tRNA^Leu^ do not disrupt the tertiary base pairs and may reinforce the stacking among G^+^15-C48-A20, A14-s^4^U8-A21 and G^+^13-A22-s^4^U9 tertiary base pairs.

![Predicted tertiary interactions of G^+^13 and G^+^15 in tRNA^Leu^. Architecture of the three-dimensional cores of *T. thermophilus* tRNA^Ser^ (**A**) and yeast tRNA^Phe^ (**B**) are compared. These presentations of tRNA architectures are based on the reference ([@B58]). The nucleotides at positions 13 and 15 and at positions 9, 20, 22 and 48 are highlighted in red and cyan, respectively. 7-Formamidino groups (indicated in red) in G^+^13 (**C**) and G^+^15 (**D**) are manually placed onto the tertiary base pairs in *T. thermophilus* tRNA^Ser^.](gkv1522fig9){#F9}

In this study, we focused on the multisite-specificity of *T. acidophilum* ArcTGT. Therefore, the phenotype of *T. kodakarensis ΔarcTGT* strain was not investigated in details. Under the tested conditions, no growth delay was observed. This growth phenotype is in line with the phenotype of *H. volcanii ΔarcTGT* strain ([@B26]). Therefore, the other modifications in tRNA seem to compensate for the stability of tRNA in the *ΔarcTGT* strain.

This study revealed that at least *T. kodakarensis* ArcS acts on both positions 13 and 15. Although the tRNA recognition mechanism by ArcS has not been reported, our current study suggests that ArcS possesses a relatively broad site-specificity. ArcS is composed of four domains, the N-terminal Zn-binding, catalytic, C2 and C3 (PUA) domains ([@B16]). The obvious differences between ArcS and ArcTGT are the location of the catalytic domain and the size of the N-terminal domain: the C1 domain in ArcTGT is replaced by the catalytic domain in ArcS and the N-terminal 70--130 amino acid residues in ArcTGT is missing in ArcS. Several conserved residues such as Asp95, Ser96 and Phe99 in the ArcTGT (the numbering is based on *P. horikoshii* ArcTGT), which interact with the D-loop in tRNA ([@B29]), are missing in ArcS. Therefore, the absence of N-terminal region may cause the broad site-specificity of ArcS. To clarify this, studies focusing on ArcS are necessary.

In this study, we developed the ArcTGT expression system in archaea instead of *E. coli*. Recently, several genetic manipulation systems in archaea have been developed ([@B26],[@B46],[@B47],[@B61]--[@B65]). Indeed, the *arcTGT* gene in *H. volcanii* was experimentally confirmed by using a gene disruption system ([@B26]). However, a genetic manipulation system in *T. acidophilum* has not been reported. Therefore, we used the *T. kodakarensis* for this study. *Thermococcus kodakarensis*, a hyperthermophilic archaeon, was isolated from a solfatara on Kodakara Island, Japan ([@B66]). The complete genome sequence was determined ([@B67]) and several genetic manipulation systems have been devised ([@B46],[@B47],[@B61],[@B64],[@B65]). One of advantages of *T. kodakarensis* genetic manipulation system is that multiple genes can be deleted or altered in the genome. At the beginning of this study, we assumed that *T. acidophilum* ArcS might be required for the G^+^13 modification in addition to *T. acidophilum* ArcTGT. Therefore, we developed the KUWA strain, in which three nutrient markers are available. These markers can also be used for the introduction of a plasmid vector. Indeed, tRNA^Leu^ genes were supplied by plasmid vectors in this study. Although tRNA modifications and tRNA modification enzymes from *T. kodakarensis* have not been reported, the genetic manipulation system of this archaeon can be utilized for studies on many proteins beyond tRNA modification enzymes.
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